SF3B1 mutation and ATM deletion codrive leukemogenesis via centromeric R-loop dysregulation.
Cancer
DNA repair
Oncology
Journal
The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877
Informations de publication
Date de publication:
01 09 2023
01 09 2023
Historique:
received:
12
07
2022
accepted:
12
07
2023
medline:
4
9
2023
pubmed:
18
7
2023
entrez:
18
7
2023
Statut:
epublish
Résumé
RNA splicing factor SF3B1 is recurrently mutated in various cancers, particularly in hematologic malignancies. We previously reported that coexpression of Sf3b1 mutation and Atm deletion in B cells, but not either lesion alone, leads to the onset of chronic lymphocytic leukemia (CLL) with CLL cells harboring chromosome amplification. However, the exact role of Sf3b1 mutation and Atm deletion in chromosomal instability (CIN) remains unclear. Here, we demonstrated that SF3B1 mutation promotes centromeric R-loop (cen-R-loop) accumulation, leading to increased chromosome oscillation, impaired chromosome segregation, altered spindle architecture, and aneuploidy, which could be alleviated by removal of cen-R-loop and exaggerated by deletion of ATM. Aberrant splicing of key genes involved in R-loop processing underlay augmentation of cen-R-loop, as overexpression of the normal isoform, but not the altered form, mitigated mitotic stress in SF3B1-mutant cells. Our study identifies a critical role of splice variants in linking RNA splicing dysregulation and CIN and highlights cen-R-loop augmentation as a key mechanism for leukemogenesis.
Identifiants
pubmed: 37463047
pii: 163325
doi: 10.1172/JCI163325
pmc: PMC10471171
doi:
pii:
Substances chimiques
Phosphoproteins
0
RNA Splicing Factors
0
SF3B1 protein, human
0
ATM protein, human
EC 2.7.11.1
Ataxia Telangiectasia Mutated Proteins
EC 2.7.11.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCI NIH HHS
ID : R01 CA240910
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA216273
Pays : United States
Références
Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13938-43
pubmed: 23918391
Cell Rep. 2018 May 8;23(6):1891-1905
pubmed: 29742442
Nat Genet. 2021 May;53(5):707-718
pubmed: 33846634
Mol Cell. 2017 Nov 16;68(4):745-757.e5
pubmed: 29104020
Nat Rev Clin Oncol. 2018 Mar;15(3):139-150
pubmed: 29297505
STAR Protoc. 2022 Dec 16;3(4):101823
pubmed: 36595959
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Nature. 2020 Jul;583(7818):711-719
pubmed: 32728246
Cancer Cell. 2016 Sep 12;30(3):404-417
pubmed: 27622333
Mol Cell. 2018 Feb 1;69(3):412-425.e6
pubmed: 29395063
N Engl J Med. 2011 Dec 29;365(26):2497-506
pubmed: 22150006
Cancer Res. 2022 Mar 01;82(5):819-830
pubmed: 35027467
Cancer Cell. 2015 May 11;27(5):617-30
pubmed: 25965569
Nature. 2012 Jan 04;481(7381):389-93
pubmed: 22217937
Sci Rep. 2017 Apr 4;7(1):595
pubmed: 28377607
Cancer Cell. 2015 May 11;27(5):631-43
pubmed: 25965570
Cell. 2013 Dec 19;155(7):1479-91
pubmed: 24360272
Cell Death Dis. 2021 Oct 1;12(10):896
pubmed: 34599155
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Rev Dis Primers. 2017 Jan 19;3:16096
pubmed: 28102226
Nature. 2021 Feb;590(7846):492-497
pubmed: 33505027
Nat Rev Genet. 2020 Jan;21(1):44-62
pubmed: 31548659
Cell Mol Life Sci. 2021 Dec;78(23):7145-7160
pubmed: 34633481
PLoS Genet. 2014 Sep 18;10(9):e1004630
pubmed: 25233079
Nature. 2021 Dec;600(7890):748-753
pubmed: 34853474
Proc Natl Acad Sci U S A. 2018 Oct 30;115(44):E10437-E10446
pubmed: 30322915
Cell Rep. 2015 Nov 3;13(5):1033-45
pubmed: 26565915
Nat Commun. 2018 Oct 18;9(1):4340
pubmed: 30337534
Nat Commun. 2018 Oct 19;9(1):4346
pubmed: 30341290
Nature. 2021 Feb;590(7846):486-491
pubmed: 33505028
Nat Rev Mol Cell Biol. 2013 Apr;14(4):197-210
pubmed: 23847781
Mol Cell. 2014 Feb 6;53(3):484-97
pubmed: 24507716
Nature. 2015 Oct 22;526(7574):525-30
pubmed: 26466571
Genome Res. 2009 Sep;19(9):1639-45
pubmed: 19541911
Genome Res. 2017 Jun;27(6):1063-1073
pubmed: 28341774
Leukemia. 2020 Sep;34(9):2525-2530
pubmed: 32076118
Nat Med. 2021 Jul;27(7):1239-1249
pubmed: 34239136
PLoS Genet. 2011 Dec;7(12):e1002386
pubmed: 22144908
Science. 2018 Jan 5;359(6371):108-114
pubmed: 29170278
Trends Cancer. 2019 Oct;5(10):619-631
pubmed: 31706509
Bioinformatics. 2015 Jul 15;31(14):2382-3
pubmed: 25765347
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Nat Rev Genet. 2014 Oct;15(10):689-701
pubmed: 25112293
Mol Cell. 2011 Nov 18;44(4):597-608
pubmed: 22099307
Nature. 2015 Jul 2;523(7558):53-8
pubmed: 26106861
Nat Commun. 2021 Nov 26;12(1):6934
pubmed: 34836941
Nucleic Acids Res. 2022 Jan 7;50(D1):D303-D315
pubmed: 34792163
Cancer Cell. 2016 Nov 14;30(5):750-763
pubmed: 27818134
Mol Cell Biol. 2018 Aug 28;38(18):
pubmed: 29941491
Blood. 2019 Mar 7;133(10):1049-1059
pubmed: 30670442
Mol Biol Cell. 2021 Jan 1;32(1):74-89
pubmed: 33147102
EMBO J. 2017 Dec 1;36(23):3532-3547
pubmed: 29074626
Cell Cycle. 2014;13(7):1091-100
pubmed: 24553124
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Cancer Cell. 2019 Feb 11;35(2):283-296.e5
pubmed: 30712845
Cancer Res. 2021 Sep 1;81(17):4499-4513
pubmed: 34215620
Mol Cell. 2021 May 6;81(9):1920-1934.e9
pubmed: 33689748
Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):E5593-601
pubmed: 25480548
Ann Hematol. 2008 Jul;87(7):515-26
pubmed: 18414863
Genome Res. 2018 Sep;28(9):1405-1414
pubmed: 30108179
Brief Bioinform. 2013 Mar;14(2):178-92
pubmed: 22517427
Nature. 2020 Sep;585(7824):298-302
pubmed: 32669707
Nat Commun. 2017 Mar 14;8:14725
pubmed: 28290446
Int J Mol Sci. 2017 Jun 23;18(7):
pubmed: 28644387
Blood Cancer Discov. 2023 May 1;4(3):228-245
pubmed: 37067905